A preliminary clinical study in the use of misonidazole in cancer of the head and neck.

  • 1 June 1978
    • journal article
    • clinical trial
    • Vol. 3, 314-7
Abstract
The value of misonidazole in advanced head and neck cancer was examined in 3 ways and the preliminary results are reported in a randomized study with large fractions of irradiation, when misonidazole appeared to confer no advantage; whereas in previously (partially) treated patients misonidazole was possibly useful. The combination of hyperbaric oxygen and misonidazole did not appear to be toxic.

This publication has 0 references indexed in Scilit: